Dexcom INC DEXCOM ORD SHS
Dexcom INC DEXCOM ORD SHS/ US2521311074 /
0A4M
13/05/2024 16:39:05
|
Chg.
-
|
Volume |
Bid06:00:05 |
Ask06:00:05 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
126.03USD
|
-
|
1,743 Turnover: 3,654.87 |
-Bid Size: - |
-Ask Size: - |
44.52 bill.USD |
- |
79.96 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
1.40 USD |
59.09% |
EPS Diluted: |
1.30 USD |
58.54% |
Revenues per Share: |
9.40 USD |
24.78% |
Book Value per Share: |
5.37 USD |
-2.74% |
Cash Flow per Share: |
1.94 USD |
12.06% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
3,622.30 USD |
24.49% |
Net Income: |
541.50 USD |
58.70% |
Operating Cash Flow: |
748.50 USD |
- |
Cash and Cash Equivalents: |
566.30 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
79.96 |
88.64 |
P/S Ratio: |
11.91 |
13.21 |
P/BV ratio: |
20.86 |
23.13 |
P/CF Ratio: |
57.65 |
63.91 |
PEG: |
1.35 |
1.50 |
Earnings Yield: |
1.25% |
1.13% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
44.52 bill. USD |
47.84 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
397.68 mill. |
|
Profitability
Gross Profit Margin: |
63.19% |
EBIT Margin: |
16.50% |
Net Profit Margin: |
14.95% |
Return on Equity: |
26.18% |
Return on Assets: |
8.64% |
Financial Strength
Liquidity I / Cash Ratio: |
36.39% |
Liquidity II / Quick Ratio: |
98.98% |
Liquidity III / Current Ratio: |
284.44% |
Debt / Equity Ratio: |
202.84% |
Dynam. Debt / Equity Ratio: |
560.57% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
31/12/2023 |
Accounting Standard: |
US GAAP |